Does Medicare Part D Cover Ozempic for Weight Loss? 2026 Criteria
If you’re a Medicare beneficiary wondering whether Ozempic can help you lose weight and whether Part D will pay for it, because the rules are far more restrictive than commercial insurance. Below we detail the 2026 coverage criteria, the cardiovascular disease requirement, costs, and alternatives.
The 2026 Medicare Part D Ozempic Policy
The short answer: Medicare Part D does cover Ozempic for type 2 diabetes — but does not cover it for weight loss alone.
What you need to understand:
For type 2 diabetes: Most Medicare Part D plans include Ozempic (semaglutide 0.5-2 mg injection) on their formularies for glycemic control. Expect Tier 3 or Tier 4. Prior authorization is standard.
For weight loss: Medicare Part D explicitly excludes cover Ozempic for obesity or weight management. Medicare has never covered medications prescribed solely for weight loss. A narrow pathway opened in 2024: semaglutide (as Wegovy) was approved for cardiovascular risk reduction in patients with established atherosclerotic cardiovascular disease.
This means: if you have a history of heart attack, stroke, or PAD, Medicare Part D will potentially pay for Wegovy (semaglutide 2.4 mg) under the cardiovascular risk reduction indication — but not Ozempic for that purpose, because the CVD label is specific to Wegovy, not Ozempic.
CVD Criteria Explained
For Medicare beneficiaries hoping to access semaglutide the cardiovascular risk reduction indication:
You must have documented:
- Prior myocardial infarction (heart attack) — verified by cardiology
- Prior stroke (cerebrovascular accident) — with neurological documentation
- Peripheral artery disease (PAD) — diagnosed by vascular studies
Conditions that don’t meet the threshold:
- High cholesterol alone
- Uncontrolled BP
- Elevated BMI without ASCVD
- Metabolic syndrome
- Family history of heart disease
Most seniors seeking weight loss will not qualify. A 2025 Kaiser Family Foundation analysis found that approximately 1 in 7 obese Medicare patients meet the ASCVD criteria.
Copay Information
For the diabetes indication:
| Coverage Phase | What You Pay |
|---|---|
| Initial coverage (after deductible) | $80-$250/month (25-33% coinsurance) |
| Coverage gap (“donut hole”) | $250-$400/month |
| Catastrophic coverage | $0-$50/month (5% coinsurance) |
The 2025 Inflation Reduction Act cap, Medicare Part D the annual maximum is $2,000 per year for all prescription drugs. This means, even if Ozempic is expensive initially, costs are bounded.
NovoCare programs cannot be used with Medicare Part D — government plan members are excluded from manufacturer card programs.
PA Process
Most Part D formularies mandate prior authorization for Ozempic:
- Type 2 diabetes confirmation: HbA1c results from the past 6 months
- Metformin trial: Typically you must show a trial of metformin. Some plans also want to see a sulfonylurea trial.
- Provider statement: Why Ozempic over cheaper alternatives
Processing time: 24-72 hours for standard requests (Medicare has stricter PA timelines than commercial plans). Rush review: same-day for time-sensitive cases.
Medicare Appeal Process
Medicare Part D has a structured multi-level appeal process:
- Coverage determination redetermination: File within the appeals window with new documentation
- Independent Review Entity (IRE): Automatic escalation if Level 1 fails
- Administrative Law Judge (ALJ): Judicial review — available when the claim exceeds approximately $200
- Medicare Appeals Council: Council review of ALJ decision
- Level 5: The last legal option
Pay close attention to deadlines: expedited appeals within 72 hours.
Not eligible for Medicare Ozempic coverage? Compounded semaglutide is available from licensed US telehealth providers for $199/month without insurance.
What Else Can You Do?
- Medicare Wegovy Coverage — worth checking if you have ASCVD
- Medicare Mounjaro Coverage — another GLP-1 option for Medicare patients
- Medicare Zepbound Coverage — understand the restrictions
- Medicare Rybelsus Coverage — the pill-form option
- Kaiser Ozempic Coverage — if you have Kaiser Medicare Advantage
Frequently Asked Questions
Does Medicare Part D cover Ozempic for weight loss?
No. Medicare Part D does not cover Ozempic for weight loss. Coverage is limited to the glycemic control indication. Heart disease risk reduction is available only through Wegovy.
How much does Ozempic cost on Medicare Part D?
Expect to pay $80-$400/month depending on your coverage phase. The $2,000 annual out-of-pocket cap limit your total drug spending.
Can I get Ozempic for weight loss on Medicare Advantage?
No — the same exclusions apply. The Medicare statutory exclusion applies unless the cardiovascular indication qualifies — and that routes through Wegovy.
Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. Medicare coverage policies are complex and change annually. Consult your healthcare provider and your Medicare Part D plan for personalized guidance.